drugset / Trial / NCT01382303
Effect of Pentoxifylline on Proteinuria in Korean Type 2 Diabetic Patients
Phase 4
Completed
174 enrolled
Ajou University School of Medicine
Bundang CHA Hospital · collabGangnam Severance Hospital · collabHallym University Medical Center · collabMyongji Hospital · collabYonsei University · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
This multi-center, randomized controlled study aims to evaluate the effects of pentoxifylline on proteinuria in Korean type 2 diabetic patients.
Timeline
- Start
- 2010-10-25
- Primary completion
- 2013-12-20
- Completion
- 2013-12-20
Publications
- Colombijn JM, Hooft L, Jun M, Webster AC, Bots ML, Verhaar MC, Vernooij RW. Antioxidants for adults with chronic kidney disease. Cochrane Database Syst Rev. 2023 Nov 2;11(11):CD008176. doi: 10.1002/14651858.CD008176.pub3.
- Han SJ, Kim HJ, Kim DJ, Sheen SS, Chung CH, Ahn CW, Kim SH, Cho YW, Park SW, Kim SK, Kim CS, Kim KW, Lee KW. Effects of pentoxifylline on proteinuria and glucose control in patients with type 2 diabetes: a prospective randomized double-blind multicenter study. Diabetol Metab Syndr. 2015 Jul 19;7:64. doi: 10.1186/s13098-015-0060-1. eCollection 2015.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Pentoxifylline | Small molecule | 400 mg | — |